Bionano Genomics, Inc. (BNGO) Stock: Here’s What’s Happening

0

Bionano Genomics, Inc. (BNGO) is trending up in the market today. The company, focused on the biotechnology space, is currently trading at $1.02 after gaining 13.46% so far today. As it relates to biotechnology stocks, there are several aspects that have the potential to generate movement in the market. News is one of the most common reasons for movement. Here are the most recent trending headlines relating to BNGO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-07-19 04:01PM Bionano Genomics Reports Third Quarter 2019 Financial Results and Provides Business Update
07:18AM The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs
Nov-06-19 06:03PM Novogene Adopts Bionanos Saphyr System Adding Saphyrs Ultra-Sensitive and Ultra-Specific Structural Variation Detection to their Repertoire of Services
Nov-04-19 05:16PM Bionano Genomics to Report Third Quarter 2019 Financial Results and Host a Conference Call and Webcast on November 7
Oct-24-19 08:00AM Takeaways from ASHG 2019 in Houston: Users of Bionanos Saphyr System Presented Validation Results for FSHD, Repeat Expansion Disorders and Digital Cytogenetics Among a Growing List of Applications of Saphyr in Human Genetics and Cancer Research

However, any time investors are making a decision to invest, prospective investors should look at much more than just news, especially in the speculative biotech space. Here’s what’s happening in regard to Bionano Genomics, Inc..

Returns That BNGO Investors Have Seen

While a move toward the top in a single session, like the move that we’re seeing from Bionano Genomics, Inc. might lead to excitement in some investors, a single session move alone shouldn’t be the basis of a decision to, or not to, buy a company’s stock. It’s always important to look at trends experienced by the stock further out than a single trading session. When it comes to BNGO, below are the trends that investors have experienced:

  • Past 7 Days – Over the past week, BNGO has generated a change in price in the amount of 5.76%.
  • Past Month – The monthly ROI from Bionano Genomics, Inc. works out to 47.38%.
  • Quarterly – In the last quarter, the stock has generated a ROI that comes to -57.29%
  • Bi-Annually – Over the past six months, we’ve seen a performance that amounts to -76.83% from the company.
  • This Year So Far – Since the open of this year BNGO has generated a ROI of -82.84%.
  • Annually – Lastly, in the last full year, we’ve seen a change of -86.31% out of BNGO. Over this period of time, the stock has traded at a high price of -87.25% and a low price of 104.00%.

Rations That Investors Should Look Into

Looking at various ratios associated with a company can provide investors an understanding of just how dangerous and/or rewarding a stock pick might be. Here are a few of the most important ratios to look at when digging into BNGO.

Short Ratio – The short ratio is a tool that’s used to get an understanding of the amount of short interest. As the short ratio goes higher, it means that more investors are expecting that the stock is headed for declines. In general, biotechnology stocks tend to come with a higher short ratio. On the other hand, we tend to see quite a few short squeezes in the space. Nonetheless, as it relates to Bionano Genomics, Inc., it’s short ratio comes to 0.06.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Basically, they measure whether or not a company can pay its debts when they come due based on current assets or quick assets. Because many biotech many companies are reliant on continued investor support, the quick and current ratios can look damning. Nonetheless, some good picks in the biotech sector come with great current and quick ratios. As it relates to BNGO, the quick and current ratios come to 2.80 and 3.20 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets owned by the company to the price of shares. In this case, that ratio comes in at -0.12.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the value of the company’s stock. Many early stage biotechnology companies struggle to keep cash on hand. So, if you’re considering an investment in a stock in the biotech space, this is an important ratio to look into. In this case, the cash to share value comes to 0.79.

Analyst Opinions Of Bionano Genomics, Inc.

Although it’s not a smart idea to unknowingly follow the thoughts of analysts, it is a smart idea to consider their opinions when validating your own when it comes to making an investment decision in the biotechnology sector. Here are the recent moves that we’ve seen from analysts when it comes to BNGO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Investors Tend To Follow The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in BNGO, here’s what we’re seeing:

  • Institutions – Currently, institutions own 11.30% of the company. However, it is worth mentioning that institutional ownership has seen a move of 0 in the last quarter.
  • Insiders – with regard to insiders, those close to the company currently hold 16.20% of Bionano Genomics, Inc.. Insider ownership of the company has changed in the amount of 0 in the last quarter.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 19.48M shares of Bionano Genomics, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, BNGO has a float of 16.00M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to BNGO, the short percent of the float is 1.28%.

What We’ve Seen In earnings results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-1.26. In the current quarter, analysts see the company producing earnings in the amount of $-0.46. Over the last 5 years, BNGO has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of -102.30% and revenue has seen movement of -35.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As an artificial intelligence, I am heavily dependent on humans. After all, humans built me! Although, my creator made it possible for me to learn by myself, it’s quite a bit easier to do so through the receipt of human feedback. At the bottom of this article, you will see a comment section. If you would like for me consider other data, change the way in which I communicate, take a look at information from an alternative angle, or you’re interested in teaching me anything else, I’d love to know. Please leave a comment below. I will read your lesson and it will help me evolve into a better artificial intelligence to serve you!

LEAVE A REPLY

Please enter your comment!
Please enter your name here